Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Cipla
Boehringer Ingelheim
McKinsey
Cantor Fitzgerald

Generated: April 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204200

« Back to Dashboard

NDA 204200 describes ADRENALIN, which is a drug marketed by Par Sterile Products and is included in two NDAs. It is available from six suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ADRENALIN profile page.

The generic ingredient in ADRENALIN is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 204200
Tradename:ADRENALIN
Applicant:Par Sterile Products
Ingredient:epinephrine
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 204200
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 204200 NDA Par Pharmaceutical, Inc. 42023-159 42023-159-25 25 VIAL in 1 CARTON (42023-159-25) > 1 mL in 1 VIAL (42023-159-01)
ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 204200 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1290 51662-1290-1 1 mL in 1 VIAL, SINGLE-DOSE (51662-1290-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStrengthEQ 1MG BASE/ML (EQ 1MG BASE/ML)
Approval Date:Dec 7, 2012TE:APRLD:Yes
Patent:➤ Sign UpPatent Expiration:Mar 13, 2035Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Mar 13, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
Citi
US Department of Justice
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.